Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_assertion type Assertion NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_head.
- NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_assertion description "[Using the HER-2/neu oncogenic protein as a model, a well-defined tumor antigen in breast cancer, we questioned whether patients with advanced stage HER-2/neu overexpressing breast and ovarian cancers (III/IV) had evidence of pre-existent immunity to HER-2/neu.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_provenance.
- NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_assertion evidence source_evidence_literature NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_provenance.
- NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_assertion SIO_000772 11072789 NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_provenance.
- NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_assertion wasDerivedFrom befree-2016 NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_provenance.
- NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_assertion wasGeneratedBy ECO_0000203 NP300097.RAUgSvf0c5xeSMHRMx2jnxwyTpEWNUEY-9AAKDfdtSL3g130_provenance.